Concepedia

Julie Rosenberg

JR

Statistics

Publications

6

Citations

347

H-Index

6

Active since

2013

Affiliations

Brigham and Women's Hospital(Current)

Harvard Global Health Institute

Harvard University

Julie Rosenberg is an author at Brigham and Women's Hospital specializing in pharmacology, oncology, and medicine.

Publications per year

2013–2020

6

Publications

6

COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now

Rebecca Weintraub, Laura Subramanian, Ami Karlage et al. · Health Affairs · 2020 · 111 citations

Public Affairs, Health Policy, Infectious Diseases +17

Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium

C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud et al. · Journal of Clinical Oncology · 2013 · 95 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer

Scott McMeekin, Don S. Dizon, James Barter et al. · Gynecologic Oncology · 2015 · 76 citations

Medicine, Oncology, Pharmacology +9

Evidence-based medicine for all: what we can learn from a programme providing free access to an online clinical resource to health workers in resource-limited settings

Yannis K. Valtis, Julie Rosenberg, Sudip Bhandari et al. · BMJ Global Health · 2016 · 28 citations · Full text

Public Affairs, Health Policy, Evidence-based Practice +16

COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines

Anthony McDonnell, Robert Van Exan, Kalipso Chalkidou et al. · RePEc: Research Papers in Economics · 2020 · 24 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 6